NCM
ARNA

Northstar Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Northstar Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$15K Hold
324
– – 0.01% 77
2019
Q2 		$19K Hold
324
– – 0.02% 76
2019
Q1 		$15K Buy
+324
New +$14.9K 0.01% 77

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Northstar Capital Management's ARNA Position: Q3 2019 in Review

Northstar Capital Management held its Arena Pharmaceuticals Inc (ARNA) position steady in Q3 2019 at 324 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #77.

Northstar Capital Management first reported a position in ARNA in Q1 2019 and has held it in 3 quarters since. The position peaked at $19K in Q2 2019. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

  • Northstar Capital Management held 324 shares of Arena Pharmaceuticals Inc worth $15K as of Q3 2019.
  • Northstar Capital Management left its Arena Pharmaceuticals Inc share count unchanged in Q3 2019.
  • Arena Pharmaceuticals Inc made up 0.01% of Northstar Capital Management's portfolio in Q3 2019, its #77 holding.
  • Northstar Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and has held it in 3 quarters since.
  • Northstar Capital Management's Arena Pharmaceuticals Inc position peaked at $19K in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Northstar Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.